Cargando…
Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
Cuproptosis is a newly discovered new mechanism of programmed cell death, and its unique pathway to regulate cell death is thought to have a unique role in understanding cancer progression and guiding cancer therapy. However, this regulation has not been studied in low grade glioma (LGG) at present....
Autores principales: | Xu, Yifan, Wang, Chao, Li, Shifang, Zhou, Han, Feng, Yugong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633682/ https://www.ncbi.nlm.nih.gov/pubmed/36338998 http://dx.doi.org/10.3389/fgene.2022.975419 |
Ejemplares similares
-
Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
por: Yang, Xiaojing, et al.
Publicado: (2022) -
An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020) -
Foreboding lncRNA markers of low-grade gliomas dependent on metabolism
por: Lu, Zhuangzhuang, et al.
Publicado: (2022) -
A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
por: Cai, Jinming, et al.
Publicado: (2023) -
A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)